Analysed Crispr Therapeutics AG (CRSP:NASDAQ) News Sources
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kyntra Bio (KYNB), Crispr Therapeutics AG (CRSP) and GoodRx Holdings (GDRX)
The Globe and Mail
Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
Yahoo Finance
DelveInsight Business Research, LLP: Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
FinanzNachrichten.de
What is the current price of Crispr Therapeutics AG (CRSP:NASDAQ)?
The current price of Crispr Therapeutics AG (CRSP:NASDAQ) is $56.5.
Crispr Therapeutics AG (CRSP:NASDAQ) absolute price change since previous trading day?
The absolute price change of Crispr Therapeutics AG (CRSP:NASDAQ) since the previous trading day is $-0.83.
Crispr Therapeutics AG (CRSP:NASDAQ) percentage price change since previous trading day?
The percentage price change of Crispr Therapeutics AG (CRSP:NASDAQ) since the previous trading day is -1.45%.
What is This Week's average sentiment score for Crispr Therapeutics AG (CRSP:NASDAQ)?
This Week's average sentiment score for Crispr Therapeutics AG (CRSP:NASDAQ) is 87 out of 100.
What is This Week's average sentiment for Crispr Therapeutics AG (CRSP:NASDAQ)?
This Week's sentiment for Crispr Therapeutics AG (CRSP:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.